Clinical Study Results
How many participants had adverse reactions?
A higher percentage of participants in Part A had adverse reactions compared to
participants in Part B.
A higher percentage of participants in Part A had serious adverse reactions compared
to participants in Part B.
None of the participants in Part A stopped treatment because of adverse reactions they
had during the study. Some of the participants in Part B stopped treatment because of
adverse reactions they had during the study.
The table below shows how many participants had adverse reactions during the study.
Adverse reactions during the study
Part A 200 mg Part A 175 mg Part B 175 mg
AZD1775 AZD1775 AZD1775 Total
(out of 7 (out of 5 (out of 80 (out of 92
participants) participants) participants) participants)
How many participants
had adverse reactions 100.0% (7) 80.0% (4) 83.8% (67) 84.8% (78)
during the study?
How many participants
had serious adverse
14.3% (1) 20.0% (1) 10.0% (8) 10.9% (10)
reactions during the
study?
How many participants
stopped treatment
0.0% (0) 0.0% (0) 3.8% (3) 3.3% (3)
because of adverse
reactions?
9